Conference Detail Page

Neurology: Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study

CME : 0.75
Start Date :  Jan 23 - 2018 End Date :  Jan 23 - 2021

Organized by :   American Academy of Neurology (AAN)

Specialities :   Neurology, Midwifery

Conference Summary

Neurology: Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study is organized by American Academy of Neurology (AAN).

Released: 1/23/2018
Expires: 1/23/2021

Accreditation:
The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the article by Hernandez-Diaz et al, the participant should be able to:
• State differences between women taking topiramate and women unexposed to topiramate in this study
• Discuss the relative risk of oral clefts in infants exposed to topiramate in this study compared to infants who were unexposed or exposed to lamotrigine
• Discuss factors which increased the risk of oral clefts in infants exposed to topiramate

Credit Info

  • CME : 0.75
Author (s)
2 Speakers
Target Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Peers Info
Number of Health Care Professionals Registered: 1 Number
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat